Cumberland Pharmaceuticals Inc.CPIXNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank50
3Y CAGR-5.9%
5Y CAGR-0.7%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-5.9%/yr
vs -2.2%/yr prior
5Y CAGR
-0.7%/yr
Recent deceleration
Acceleration
-3.7pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$5.57M+15.6%
2024$4.82M-17.4%
2023$5.83M-12.8%
2022$6.69M+17.7%
2021$5.68M-1.5%
2020$5.77M-15.9%
2019$6.87M-6.2%
2018$7.32M+87.6%
2017$3.90M+22.3%
2016$3.19M-